ANNUAL REPORT OF RANBAXY 2010-11 PDF

0 Comments

Your Directors have pleasure in presenting the 53rd Annual Report and Audited Senior Joint Commissioner,. Kolkata. Delhi Value Added Tax. Ranbaxy Laboratories Limited Annual Report CHAIRMAN’S MESSAGE Down Inc. Germany (upto 16 December ) 11 Ranbaxy Unichem Co. Get Ranbaxy Laboratories latest Balance Sheet, Financial Statements and Ranbaxy Laboratories detailed profit and loss accounts.

Author: Kizragore Faetilar
Country: Ecuador
Language: English (Spanish)
Genre: Education
Published (Last): 1 January 2011
Pages: 33
PDF File Size: 17.39 Mb
ePub File Size: 7.67 Mb
ISBN: 447-9-40332-286-6
Downloads: 85224
Price: Free* [*Free Regsitration Required]
Uploader: Votaxe

The Company is in dialogue with these regulatory agencies and is addressing their concerns.

Ranbaxy Laboratories

The amount is excluding interest and penalty, if any. The Company expects to resume the operations shortly.

Options are granted at the discretion of the committee to selected employees depending upon certain criterion. The same is expected to be resumed shortly.

Annual Reports & Presentations | Sun Pharmaceutical Industries Ltd.

Segment repott In accordance with AS 17, Segment Reporting, segment information has been given in the consolidated fnancial statements of the Company, and therefore, no separate disclosure on segment information is given in these fnancial statements.

Key markets of US, Europe not so promising 27 Oct 09 Free reports will not be deducted from your subscription. Related party disclosures A] Names of related parties Related parties where control exists with whom no transactions have taken place during the current period or previous year: The Company expects to resume API bulk shipments to EU countries from Toansa manufacturing xnnual upon receipt of clearances from relevant regulatory authorities. If the shares are listed on more than one stock exchange, then the stock exchange where there is highest trading volume on the said date shall be considered.

Related Posts  FOSECO NON-FERROUS FOUNDRYMAN HANDBOOK PDF

The sales consideration of Rs. Due to the nature of these disputes and also in view of signifcant uncertainty of outcome, the Company believes that the amount of exposure cannot be currently determinable.

Company overview Ranbaxy Laboratories Limited ”the Company” together with its subsidiaries and associates, operates as an integrated international pharmaceutical organisation with businesses encompassing the entire value chain in the marketing, production and distribution of pharmaceutical products.

The options vests evenly over ranbayx period of fve years from the date of grant. It is the largest exporter of bulk drugs and pharmaceutical dosag. Nifty pares losses; Ranbaxy,Cipla lead 25 Sep 09 Ranbaxy gets approval from Japan for Dewas unit; stk up 24 Jul 09 Nifty bounces over ; Bharti languishes 17 Feb 10 Options lapse, if they are not exercised prior to the annial date, which is ten years from the date of grant.

Ranbaxy Laboratories Limited (BSE Code: ) annual reports starting from year

The Company will issue shares to the Trust which will allocate the shares to the respective employees upon ranbaxh of stock options from time to time under ESOP – The options vests evenly over a period of three years from the date of grant. As at 31 Marchthere are no such derivative contracts which are classifed as cash fow hedges.

Ranbaxy UK Limited, U. Pending disposal of the matter, the management considers the impact as unascertainable.

Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium anhual express written permission of moneycontrol. Commitments i Estimated amount of contracts remaining to be executed on capital account and not Description cannot exceed characters.

Related Posts  BIOFISICA BASICA IBRAHIM PDF

Your Account is not yet activated Click here to receive activation mail once again. Consequently, stock write off and other costs of Rs. The Company has also issued redeemable non-convertible debentures which are listed for trading on the NSE in India. A, Italy Ranbaxy Malaysia Sdn.

Ranbaxy Laboratories is not traded in the last 30 days. The Company has challenged the order before the Hon”ble Income Tax Appellate Tribunal ITAT and pending disposal of the matter, the management considers the amount of tax liability as unascertainable. Click here to change registered Email ID.

Consequent to the fndings of the above exercise, the carrying amount of inventory has been written down by Rs. In calculating these provisions, the management has used the best information and estimates, presently available. The following are the outstanding derivative contracts entered into by the Company: Foreign funds hint at hiking India allocation 25 Mar 10 Please do reach out to us at contactus reportjunction.

We are attempting to resolve this funny technical issue! Hedging and derivatives a The Company uses various forms of derivative instruments such as foreign exchange forward contracts including instruments which annua in substance forward contractsoptions, currency swaps, currency cum interest rate swaps and interest rate swaps to hedge its exposure to movements in foreign exchange and interest rates.